Tragara Pharmaceuticals

Closed

Home | TragaraPharma

San Diego, United States · Founded 2007

Founded
2007
Business Model
B2B

About

Tragara Pharmaceuticals, Inc. was a privately held, San Diego-based pharmaceutical company focused on the clinical and preclinical development of novel small-molecule therapeutics for cancer and inflammation-related disorders. The company launched with a Series A financing in March 2007 and advanced compounds including TG02 (an investigational kinase inhibitor studied in Phase I trials) and Capoxigem (apricoxib), which completed enrollment in a Phase II non-small-cell lung cancer trial. Tragara also formed development partnerships, including a global agreement with S*BIO and a Greater China licensing deal with Lee's Pharmaceuticals for TG02. The company was later renamed Adastra Pharmaceuticals and acquired/merged as an operating subsidiary.

Summary

Tragara Pharmaceuticals is a Biotech company based in San Diego, United States, founded in 2007.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tragara Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/tragara-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/tragara-pharmaceuticals" alt="Tragara Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>